NIKKIA KING: Open Payments
NPI 1841850963 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$783 in 32 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $202 · 2025 $783
Food & beverage: $783
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 14 | $302 |
| AstraZeneca Pharmaceuticals LP | 3 | $156 |
| Exact Sciences Corporation | 4 | $89 |
| Lilly USA, LLC | 3 | $70 |
| Abbott Laboratories | 2 | $42 |
| SANOFI-AVENTIS U.S. LLC | 1 | $38 |
| PFIZER INC. | 2 | $34 |
| Dexcom, Inc. | 1 | $23 |
| GlaxoSmithKline, LLC. | 1 | $16 |
| ABBVIE INC. | 1 | $13 |
Products named: Ozempic, FASENRA, The Cologuard Plus Collection Kit, MOUNJARO, Rybelsus, FREESTYLE LIBRE 3, TZIELD, Wegovy.
Industry payments across MD — which companies pay providers there.
